, Tracking Stock Market Picks
Enter Symbol:
Novartis Ag (NVS) [hlAlert]

up 24.02 %

Novartis Ag (NVS) rated Buy by Natixis Bleichroeder

Posted on: Monday,  Nov 25, 2013  9:25 AM ET by Natixis Bleichroeder

Natixis Bleichroeder rated Buy Novartis Ag (NYSE: NVS) on 11/25/2013, when the stock price was $79.53. Since
then, Novartis Ag has gained 24.03% as of 01/14/2016's recent price of $98.64.
If you would have followed this Natixis Bleichroeder's recommendation on NVS, you would have gained 24.02% of your investment in 780 days.

Novartis AG, incorporated on February 29, 1996, is a Switzerland-based holding that, through its subsidiaries, is engaged in the research, development, manufacture and marketing of healthcare products. The Company?s healthcare solutions portfolio includes medicines, preventive vaccines and diagnostic tools, generic pharmaceuticals and consumer health products. Its businesses are divided on a worldwide basis into the four operating divisions: Pharmaceuticals, which comprises brand-name patented pharmaceuticals; Vaccines and Diagnostics, which focuses on human vaccines and blood-testing diagnostics; Sandoz, which consists generic pharmaceuticals, and Consumer Health, which includes over-the-counter medicines, animal health medicines, and contact lenses and lens-care products. It operates in approximately 140 countries. In September 2009, Novartis AG announced that its Sandoz division has completed the acquisition of EBEWE Pharma's specialty generic injectables business.

Natixis Bleichroeder , a US-registered broker-dealer and subsidiary of Natixis, provides its clients with corporate and investment banking solutions. Natixis is the corporate, investment and financial services arm of Groupe BPCE, France's second-largest banking group. With around 22,000 employees, Natixis specializes in three main business lines: Corporate and Investment Banking, Investment Solutions (asset management, private banking, insurance, private equity) and Specialized Financial Services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/25/2013 9:25 AM Buy
as of 12/13/2013
1 Week down  -2.47 %
1 Month down  -3.38 %
3 Months   
1 YTD down  -3.38 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy